Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab
| Autor: | Emilio Bria, Vanni B, Cuppone F, Calabretta F, Campanella C, Torsello A, Terzoli E |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2004 |
| Předmět: |
breast cancer
taxanes trastuzumab Endpoint Determination Antibodies Monoclonal Breast Neoplasms Antibodies Monoclonal Humanized Combined Modality Therapy Survival Analysis Treatment Outcome Clinical Trials Phase III as Topic Antineoplastic Combined Chemotherapy Protocols Humans Female Taxoids Randomized Controlled Trials as Topic |
| Zdroj: | Europe PubMed Central |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|